Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
  • Toggle search form

[Disclosure] Celltrion Decides to Acquire 537,924 Shares of Treasury Stock Worth Approx. KRW 100B (068270)

Posted on October 25, 2024July 16, 2026 By K-STOCK Editor No Comments on [Disclosure] Celltrion Decides to Acquire 537,924 Shares of Treasury Stock Worth Approx. KRW 100B (068270)

Source Facts: Financial Supervisory Service Electronic Disclosure System (DART) / 2024-10-25

Disclosure Type: Decision on Treasury Stock Acquisition

💡 3-Second Summary

For the purpose of stock price stabilization and enhancing shareholder value, Celltrion has decided to acquire 537,924 shares of its treasury common stock (valued at approximately KRW 100B) through open-market purchases on the KRX.

📊 1. [Key Disclosure Content & Major Financial Figures Summary]

  • Acquisition Shares and Amount:
    • Share Type and Quantity: 537,924 common shares (No other classes of shares)
    • Scheduled Acquisition Payout: KRW 100,000,071,600 (Approx. KRW 100B)
    • Calculation Base: Calculated using the closing stock price on the business day prior to the board decision (October 24, 2024, at KRW 185,900); the final total payout remains subject to changes depending on daily market fluctuations.
  • Timeline and Execution Method:
    • Expected Acquisition Period: October 28, 2024 ~ January 27, 2025 (Expected holding period is at least 6 months following the final purchase date)
    • Execution Method: Direct open-market purchases on the Korea Exchange (KRX)
    • Entrusted Investment Brokers: NH Investment & Securities, Meritz Securities
  • Acquisition Limits and Current Holdings:
    • Daily Purchase Order Limit: 144,904 common shares
    • Current Treasury Share Holdings: 10,926,287 common shares (6,091,510 shares acquired within dividendable profit / 4,834,777 shares acquired via other methods)
  • Financial Limit Assessment (Commercial Act Dividendable Profit Limit):
    • Net Asset Value: KRW 17,040,573,155,434
    • Final Limit for Treasury Share Acquisition: KRW 4,244,748,633,723 (Approx. KRW 4.24T; the scheduled purchase of KRW 100B falls securely within the allowable legal thresholds)
  • Board Decision Details: Approved on October 25, 2024 (7 outside directors present, 1 absent; the audit committee is composed entirely of outside directors)

📈 2. [Expert Perspective: What This Disclosure Means for Investors]

This regulatory filing outlines Celltrion’s formal board approval to buy back approximately KRW 100B worth of common treasury stock directly from the open market to stabilize its trading price and manage public equity interest.

From a financial perspective, the proposed acquisition amount of KRW 100B is positioned well within the legal parameters, representing a minor fraction of the company’s statutory dividendable profit limit of approximately KRW 4.24T (calculated under the individual balance sheet as of December 31, 2023). This transaction will be executed progressively over a three-month period from October 28, 2024, to January 27, 2025, using nominated brokers (NH Investment & Securities, Meritz Securities). Since the target quantity was computed based on the pre-decision closing price of KRW 185,900, the absolute cash outflow required to complete the buyback will fluctuate based on daily share price developments during the purchase window.

Investors should monitor the progressive fulfillment of the buyback, ensuring that daily purchase activities remain aligned with the legally designated ceiling of 144,904 shares per day over the designated three-month execution timeframe.

📝 Editor’s Comment (by K-STOCK Editor)

This treasury stock acquisition proposal was authorized by a board vote with seven outside directors present and one absent. The primary fact is the structured operational plan to purchase an additional 537,924 common shares on top of the company’s current treasury holdings of 10,926,287 common shares.

Investors must recognize that this specific filing establishes a “planned acquisition process” and does not formulate a legally binding commitment regarding the eventual disposition or retirement of the acquired shares. Acquiring treasury shares from the open market functions primarily as a temporary measure to sequester circulating stock; it does not directly reduce the total outstanding share volume of the corporation unless followed by a formal board resolution to retire those shares.

Consequently, the objective checkpoints for investors to monitor going forward are twofold: first, the complete execution of the 537,924 common shares within the designated purchase window between October 28, 2024, and January 27, 2025; and second, the subsequent filing of any board resolutions detailing the long-term disposition or formal retirement of these accumulated treasury holdings. Systematically tracking these subsequent disclosures remains the proper pathway to measuring the absolute impact of this corporate action.

📢 Disclaimer & Source Information

Source: This content has been structured and newly drafted based on official data submitted to the Financial Supervisory Service Electronic Disclosure System (DART).

Investment Risk Warning: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial liabilities rest solely with the investor.

Inquiries: For compliance inquiries or copyright-related requests, please contact ksb220805@gmail.com.

🐂
BULLS
VS
🐻
BEARS

🔥 Bulls vs Bears, drop your analysis in the comments!

Disclosures, Bio & Healthcare

Post navigation

Previous Post: [IR] SK hynix (000660) Reports Q3 2024 Revenue of KRW 17.57T and Operating Profit of KRW 7.03T… Highlights HBM3E, 1cnm DDR5 and eSSD Product Roadmap
Next Post: [Disclosure] JUSUNG ENGINEERING (036930), Trading Suspension Confirmed for Single-Stock Futures on Oct 30 Coinciding with Demerger Schedule

Related Posts

[Disclosure] Hanamicron (067310) Additional Listing via Private CB Conversion Semiconductors
[Disclosure] Celltrion (068270) Announces Expiration of Part 1 Approval for ‘Remsima SC’ Pediatric Ulcerative Colitis Phase 3 Trial in Europe Due to Strategic Shift Bio & Healthcare
[Disclosure] Hanwha Ocean (042660) Amends Contract Amount to KRW 905.2B and Extends Expiration Date for Oceania Field Control Station (FCS) Contract Disclosures
[Disclosure] Celltrion (068270) Announces Value-up Corporate Value Enhancement Plan, Targeting KRW 5T Revenue in 2025 & 40% 3-Year Average Shareholder Return Rate Disclosures
[Disclosure] SK Hynix (000660) Announces Disposal of Treasury Shares Following Executive Stock Option Exercise Semiconductors
[Disclosure] Samsung Electro-Mechanics (009150) Announces 52nd AGM for 2025.03.19, Putting CEO Duckhyun Chang’s 3-Year Re-election on Agenda Semiconductors

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme